| ACS Chem. Biol.
| [0003]
|
| Chem. Biol.
| [0003]
|
| Prot. Eng.
| [0003]
|
| Chemistry & Biology
| [0003]
|
| Chem. & Biol.
| [0003]
|
| PNAS
| [0004]
[0181]
|
| JACS
| [0004]
[0181]
|
| Nature Biotechnol.
| [0004]
[0181]
|
| PLOS Biology
| [0004]
[0181]
|
| Chem. & Biol.
| [0004]
[0181]
|
| Protein engineering design and selection
| [0005]
|
| Chem Biol
| [0006]
|
| J. Org. Chem
| [0007]
[0194]
|
| ChemBioChem
| [0007]
[0007]
[0194]
|
| Chemical Biology
| [0010]
|
| Cell-penetrating peptides in drug development: enabling intracellular targets
| [0116]
|
| Synthesis of Proteins by Native Chemical Ligation
| [0117]
|
| Subtiligase: a tool for semisynthesis of proteins
| [0117]
|
| Tags for labeling protein N-termini with subtiligase for proteomics
| [0117]
|
| Structure-activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides
| [0155]
|
| backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administered drug lead for treating obesity
| [0155]
|
| J. Mol. Biol.
| [0183]
[0195]
|
| Biochem. Pharmacol.
| [0190]
[0202]
|
| Biochemistry
| [0194]
|
| J. of Molecular Recognition
| [0194]
|
| Phage Display in Biotechnology and Drug Discovery
| [0194]
|
| Bioorganic and Medicinal Chemistry Letters
| [0206]
|
| Medicinal Chemistry
| [0206]
|
| Nature Rev. Drug Discovery
| [0206]
|
| J. of Cardiothoracic and Vascular Anesthesia
| [0208]
|
| Br. J. Anaesth.
| [0208]
|
| Biochemistry
| [0208]
|
| Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity
| [0248]
|
| Novel peptide inhibitors of human kallikrein 2
| [0248]
|
| A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition
| [0248]
|
| A cyclic peptidylic inhibitor of murine urokinase-type plasminogen activator: changing species specificity by substitution of a single residue
| [0248]
|
| Selection of a cyclic nonapeptide inhibitor to alpha-chymotrypsin using a phage display peptide library
| [0248]
|
| Peptide exosite inhibitors of factor VIIa as anticoagulants
| [0248]
[0249]
|
| Novel peptide inhibitors of angiotensin-converting enzyme 2
| [0248]
[0249]
|
| Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library
| [0248]
|
| New inhibitors of Helicobacter pylori urease holoenzyme selected from phage-displayed peptide libraries
| [0248]
|
| Peptide inhibitor of pancreatic lipase selected by phage display using different elution strategies
| [0248]
|
| A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display
| [0248]
|
| Jr. Phage display selection of a peptide DNase II inhibitor that enhances gene delivery
| [0248]
|
| High-Throughput Screening in Drug Discovery
| [0249]
|
| Hit and lead generation: beyond high-throughput screening
| [0249]
|
| Molecular evolution of proteins on filamentous phage
| [0249]
|
| Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen
| [0249]
|
| Engineered antibodies
| [0249]
|
| Highly sensitive in vitro selections for DNA-linked synthetic small molecules with protein binding affinity and specificity
| [0249]
|
| Synthetic compound libraries displayed on the surface of encoded bacteriophage
| [0249]
|
| Encoded combinatorial chemistry
| [0249]
|
| DNA display II. Genetic manipulation of combinatorial chemistry libraries for small-molecule evolution
| [0249]
|
| Selection of optical biosensors from chemisynthetic antibody libraries
| [0249]
|
| Rapid and quantitative cyclization of multiple peptide loops onto synthetic scaffolds for structural mimicry of protein surfaces
| [0249]
|
| The exploration of macrocycles for drug discovery--an underexploited structural class
| [0249]
|
| What can a chemist learn from nature's macrocycles?--a brief, conceptual view
| [0249]
|
| Conformationally restricted cyclic nonapeptides derived from L-cysteine and LL-3-amino-2-piperidino-6-carboxylic acid (LL-acp), a potent b-turn-inducing dipeptide analogue
| [0249]
|
| A stable disulfide-free gene-3-protein of phage fd generated by in vitro evolution
| [0249]
|
| Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction
| [0249]
|
| An introduction to organosulfur chemistry
| [0249]
|
| A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues
| [0249]
|
| Protease inhibitors in the clinic
| [0249]
|
| Targeting proteases: successes, failures and future prospects
| [0249]
|
| Encoded self-assembling chemical libraries
| [0249]
|
| A novel strategy for in vitro selection of peptide-drug conjugates
| [0249]
|
| A general route for post-translational cyclization of mRNA display libraries
| [0249]
|
| Design of cyclic peptides that bind protein surfaces with antibody-like affinity
| [0249]
|